The global oncology sector is witnessing a paradigm shift as the medical community increasingly prioritizes targeted and endocrine based treatments. Cancer hormone therapy, also known as endocrine therapy, has emerged as a vital pillar in the fight against hormone sensitive malignancies, particularly breast and prostate cancers. By slowing or stopping the growth of tumors that use...